Grubman M J, Baxt B. Foot-and-mouth disease[J]. Clin Microbiol Rev, 2004, 17: 465-493.
[2]
Knowles N J, Samuel P R. Molecular epidemiology of foot-and-mouth disease virus[J]. Virus, 2003, 91: 65-80.
[3]
Eric B, Carmen M, Ruiz-Jarabo, et al. Foot-and-mouth Disease Virus Lacking the VP1 G-H loop: The Mutant Spectrum Uncovers Interactions among Antigenic Site for Fitness Gain[J]. Virology, 2001, 288: 192-202.
[4]
Karplus P A, Schultz G E. Prediction of chain flexibility in proteins[J]. Naturwissenschaften, 1985, 72: 212-213.
[5]
Jameson B A, Wolf H. The antigenic index: a novel algorithmfor predicting antigenic determinants[J]. Comput Appl Biosci, 1988, 4(1): 181-186.
[6]
Petit M C, Benkirane N, Guichard G, et al. Solution structure of a retro-inverso peptide analogue mimicking the foot-and-mouth disease virus major antigen site structural basis for its antigenic cross-reactivity with the parent pepide[J]. J Biol Chem, 1999, 274: 3686-3692.
[7]
Apostolopoulos V, Yu M, Corper A L, et al. Crystal structure of a noncanonical low affinity peptide complexed with MHC class I: a new approach for vaccine design[J]. J Mol Biol, 2002, 318(5): 1293-1305.
